Differential expression of p63 isoforms in normal tissues and neoplastic cells

Journal of Pathology

Volumn 198, Issue 4, 2002, Pages 417-427

  Nylander, Karin ^a   Vojtesek, Borek ^b   Nenutil, Rudolf ^c   Lindgren, Britta ^a   Roos, Göran ^a   Zhanxiang, Wang ^a   Sjöström, Björn ^d   Dahlqvist, Åke ^d   Coates, Philip J ^e  

^a UMEÅ UNIVERSITY   (Sweden)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^c Maternity Hospital   (Czech Republic)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adenocarcinoma; Lymphoma; p63; Squamous cell carcinoma

Indexed keywords

ISOPROTEIN; PEPTIDE ANTIBODY; PROTEIN P53; PROTEIN P63; PROTEIN P73; REAGENT;

ALPHA CHAIN; AMINO TERMINAL SEQUENCE; ARTICLE; BASAL CELL; BREAST; CANCER LOCALIZATION; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL POPULATION; CELL TYPE; COLON; COLON CARCINOMA; CONTROLLED STUDY; GENETIC CODE; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOID CELL; LYMPHOMA; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA; STEM CELL; TUMOR CELL; TUMOR GROWTH;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; DNA-BINDING PROTEINS; EPITHELIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNE SERA; LYMPHOMA; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHOPROTEINS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036900291     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1231     Document Type: Article

References (33)

1. Schmale H, Bamberger C. A novel protein with strong homology to the tumor suppressor p53. Oncogene 1997; 15: 1363-1367.
2. Osada M, Ohba M, Kawahara C, et al. Cloning and functional analysis of human p5l, which structurally and functionally resembles p53. Nature Med 1998; 4: 839-843.
3. Trink B, Okami K, Wu L, Sriuranpong V, Jeri J, Sidransky D. A new human p53 homologue. Nature Med 1998; 4: 747-748.
4. Yang A, Kagdah M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305-316.
5. Meredith SI, Kaelin WG. p53 family update: p73 and p63 develop their own identities. Cell Growth Diff 2001; 12: 337-349.
6. Senoo M, Tsuchiya I, Matsumura Y, et al. Transcriptional dysregulation of the p73L/p63/p5l/p40/KET gene in human squamous cell carcinomas: expression of βNp73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p5l. Br J Cancer 2001; 84: 1235-1241.
7. Nylander K, Bourdon JC, Bray SE, et al. Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol 2000; 190: 39-46.
8. Yang A, McKeon F. p63 and p73: p53 mimics, menaces and more. Nature Rev 2000; 1: 199-207.
9. Dohn M, Zhang S, Chen X. p63α and βNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 2001; 20: 3193-3205.
10. Parsa R, Yang A, McKeon F, Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999; 113: 1099-1105.
11. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-713.
12. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-718.
13. Pellegrini G, Dellambra E, Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001; 13: 3156-3161.
14. O'Connell JT, Mutter GL, Cviko A, et al. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol 2001; 80: 30-36.
15. Quade BJ, Yang A, Wang Y, et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 2001; 80: 24-29.
16. Signoretti S, Waltgreny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000; 157: 1769-1775.
17. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001; 25: 1054-1060.
18. Hall PA, Campbell SJ, O'Neill M, et al. The expression of the p53 homologue, p63α and βNp63α in normal and neoplastic cells. Carcinagenesis 2000; 21: 153-160.
19. Nylander K, Coates PJ, Hall PA. Characterisation of the expression pattern of p63α and βNp63α in benign and malignant oral epithelial lesions. Int J Cancer 2000; 87: 368-372.
20. Hibi K, Trink B, Patturajan M, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 1999; 97: 5462-5467.
21. Faridoni-Laurens L, Bosq J, Janot F, et al. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001; 20: 5302-5312.
22. Crook T, Nicholls JM, Brooks L, O'Nions J, Allday MJ. High level expression of βN-p63: a mechanism for the inactivation of p53 in undifferentiated carcinoma? Oncogene 2000; 19: 3439-3444.
23. Tannapfel A, Schmelzer S, Benicke M, et al. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer. J Pathol 2001; 195: 163-170.
24. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002; 8: 494-501.
25. Hall PA, Woodman AC, Campbell SJ, Shepherd NA. Expression of the p53 homologue p63α and βNp63α in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein. Gut 2001; 49: 618-623.
26. Celli J, Dujif P, Hamel BC, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999; 99: 143-153.
27. lanakiev P, Kilpatrick MW, Toudjarska I, Basel D, Beighton P, Tsipouras P. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet 2000; 67: 59-66.
28. McGrath JA, Dujif PHG, Doetsch V, et al. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet 2001; 10: 221-229.
29. Sunahara M, Shishikura T, Takahashi M, et al. Mutational analysis of p51 A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer. Oncogene 1999; 18: 3761-3765.
30. Weinberg WC, Azzoli CG, Chapman K, Levine AJ, Yuspa SH. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene 1995; 10: 2271-2279.
31. Liefer KM, Koster MI, Wang X-J, Yang A, McKeon F, Roop DR. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 2000; 60: 4016-4020.
32. Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002; 416: 560-564.
33. Djelloul S, Tarunina M, Barnouin K, Mackay A, Jat PS. Differential protein expression, DNA binding and interaction with SV 40 large tumour antigen implicate the p63-family of proteins in replicative senescence. Oncogene 2002; 21: 981-989.